Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Alice Watson. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Alice Watson or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The 2025 pharma forecast

20:15
 
Share
 

Manage episode 462771876 series 3299609
Content provided by Alice Watson. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Alice Watson or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Curious to discover what might lie ahead for industry in 2025? Join Isabel and Jade in this special episode of the EMJ GOLD podcast as they reflect on whether last year’s predictions for 2024 came true, while three special guests share their predictions and hopes for pharma in the year ahead.

The line-up includes Jennifer Schranz of Ipsen, Mercedes Diz of Almirall and EMJ’s own Dr Jonathan Sackier - all of whom share their predictions in their areas of expertise.

A little more on GOLD’s guests…

Jennifer Schranz is the Senior Vice President, Global Head of Rare Diseases at Ipsen, where she oversees the Rare Diseases therapy area with a focus on R&D strategy and execution. During her time at the business, she has led talented teams of scientists and fostered strong internal collaborations within the company, leveraging her clinical development expertise to advance Ipsen’s vision of addressing challenging rare diseases.

Mercedes Diz has over 20 years’ experience in the pharmaceutical industry, having graduated with a degree in Biochemistry and Molecular Biology from the Autonomous University of Madrid. She has worked in a number of different pharmaceutical companies, from J&J to Pfizer, and is also a keen member of the Healthcare Businesswomen’s Association. At Almirall, she leads portfolio strategy and commercial innovation for global brands, new products and digital and cultural transformation.

Dr Jonathan Sackier is Chairman at EMJ and the host of the EMJ podcast, where he utilises his experience as a physician to discuss the latest breakthroughs and challenges in the medical field with fellow practitioners and experts. Jonathan is a founding partner of many start-ups in the medical technology space and created the world’s first operating room robot.

  continue reading

295 episodes

Artwork
iconShare
 
Manage episode 462771876 series 3299609
Content provided by Alice Watson. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Alice Watson or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Curious to discover what might lie ahead for industry in 2025? Join Isabel and Jade in this special episode of the EMJ GOLD podcast as they reflect on whether last year’s predictions for 2024 came true, while three special guests share their predictions and hopes for pharma in the year ahead.

The line-up includes Jennifer Schranz of Ipsen, Mercedes Diz of Almirall and EMJ’s own Dr Jonathan Sackier - all of whom share their predictions in their areas of expertise.

A little more on GOLD’s guests…

Jennifer Schranz is the Senior Vice President, Global Head of Rare Diseases at Ipsen, where she oversees the Rare Diseases therapy area with a focus on R&D strategy and execution. During her time at the business, she has led talented teams of scientists and fostered strong internal collaborations within the company, leveraging her clinical development expertise to advance Ipsen’s vision of addressing challenging rare diseases.

Mercedes Diz has over 20 years’ experience in the pharmaceutical industry, having graduated with a degree in Biochemistry and Molecular Biology from the Autonomous University of Madrid. She has worked in a number of different pharmaceutical companies, from J&J to Pfizer, and is also a keen member of the Healthcare Businesswomen’s Association. At Almirall, she leads portfolio strategy and commercial innovation for global brands, new products and digital and cultural transformation.

Dr Jonathan Sackier is Chairman at EMJ and the host of the EMJ podcast, where he utilises his experience as a physician to discuss the latest breakthroughs and challenges in the medical field with fellow practitioners and experts. Jonathan is a founding partner of many start-ups in the medical technology space and created the world’s first operating room robot.

  continue reading

295 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play